Literature DB >> 377933

Indications for surgical replacement of the mitral valve. With particular reference to common and uncommon causes of mitral regurgitation.

N O Fowler, J M van der Bel-Kahn.   

Abstract

Mitral valve replacement is considered when there is severe mitral stenosis, severe mitral insufficiency or a combination of the two. Ordinarily, surgical replacement is considered only for patients who are in functional classes III or IV and do not respond to medical management. Patients with symptomatic mitral stenosis should be treated with mitral commissurotomy whenever possible. Patients selected for commissurotomy should have a pliable valve, no other major valve dysfunction, sinus rhythm, no systemic embolism and good left ventricular function. Early operation is not ordinarily required. Mitral insufficiency may require mitral valve replacement in six rather common settings: rheumatic disease, rupture of mitral chordae tendineae, postinfarction rupture of a papillary muscle, intractable infective endocarditis, floppy mitral valve and malfunction of a prosthetic valve. Rupture of mitral chordae tendineae can usually be recognized from the history, physical examination, echocardiogram and angiocardiogram. Severe left ventricular papillary muscle dysfunction is usually due to cardiac infarction, and occurs within the first 9 days of infarction. When only a papillary muscle tip is ruptured the patient may survive long enough for a mitral valve replacement. In infective endocarditis, operation is more often needed because of congestive heart failure than because of refractory infection. Evidence of mitral stenosis or insufficiency in a patient with a previously implanted prosthetic valve usually indicates an urgent need for study and early operation. Uncommon causes of mitral incompetence that may require valve replacement are endocardial fibroelastosis, Marfan's syndrome, calcified mitral anulus, osteogenesis imperfecta, methysergide-induced heart disease and carcinoid heart disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377933     DOI: 10.1016/0002-9149(79)90264-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.

Authors:  A E Tuinenburg; I C Van Gelder; M P Van Den Berg; J Brügemann; P J De Kam; H J Crijns
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

2.  Use of tissue Doppler echocardiography in early detection of left ventricular systolic dysfunction in patients with mitral regurgitation.

Authors:  Cem Nazli; Ozan Kinay; Oktay Ergene; Turan Yavuz; Omer Gedikli; Yesim Hoscan; Mehmet Ozaydin; Ahmet Altinbas; Abdullah Dogan; Halil Kahraman; Gurkan Acar
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

3.  Prognostic Value of Creatine Phosphate and Inflammatory Markers for Mitral Valve Replacement: A Systematic Review and Meta-Analysis.

Authors:  Yanhui Zhu; Chengwei Zou; Jun Zhang; Lei Chen; Yanting Jia
Journal:  Appl Bionics Biomech       Date:  2022-03-11       Impact factor: 1.781

Review 4.  The Evolution of Mitral Valve Surgery: the Future in the Hand of Robots.

Authors:  Amer Harky; Hiu Tat Kwok; Ka Siu Fan
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.